Table 1.
Demographic, pharmacotherapy characteristics, and epileptic condition of the children participating in the study.
| A. Demographics | |||||
|---|---|---|---|---|---|
| Characteristic | Value | ||||
| Gender | |||||
| Boys | 31 (43.7%) | ||||
| Girls | 40 (56.3%) | ||||
| Age (years) | |||||
| Mean | 10.9 | ||||
| Median | 11 | ||||
| Interquartile range | 7 | ||||
| Body weight (kg) | |||||
| Mean | 37.1 | ||||
| Median | 35 | ||||
| Interquartile range | 21 | ||||
| B. Pharmacotherapy and epileptic condition | |||||
| Therapeutic regimen | Number (%) | Male (%) | Female (%) | Without epileptic seizure | With epileptic seizure |
| VA/LTG | 42 (59.16) | 19 (45.24) | 23 (54.76) | 37 (88.1) | 5 (11.9) |
| VA/LEV | 20 (28.17) | 8 (40) | 12 (60) | 14 (70) | 6 (30) |
| LTG/LEV | 9 (12.67) | 4 (44.44) | 5 (55.56) | 5 (55.6) | 4 (44.4) |
LEV, levetiracetam; LTG, lamotrigine; VA, valproic acid.